• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病中的家族和种族风险。

Familial and ethnic risk in inflammatory bowel disease.

作者信息

Santos Maria Pia Costa, Gomes Catarina, Torres Joana

机构信息

Gastroenterology Division, Surgical Department, Hospital Beatriz Ângelo, Loures, Portugal.

出版信息

Ann Gastroenterol. 2018 Jan-Feb;31(1):14-23. doi: 10.20524/aog.2017.0208. Epub 2017 Oct 26.

DOI:10.20524/aog.2017.0208
PMID:29333063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5759609/
Abstract

Familial aggregation in inflammatory bowel disease (IBD) has been established for several decades, reflecting shared genetic and environmental susceptibility. A positive family history remains the strongest recognizable risk factor for the development of IBD and is reported in around 8-12% of IBD patients. Crohn's disease shows a more frequent familial pattern than ulcerative colitis. The risk of developing IBD in first-degree relatives of an affected proband is increased 4- to 8-fold. The risk for twins and children born from couples who both have IBD is also substantially higher; a cumulative effect of the number of family members affected has been described, with the highest incidence being described for families with three or more affected members. Herein, we review the available evidence regarding familial IBD, and briefly discuss the variation of IBD across different races and ethnicities, hoping to provide a useful update and a practical guide that can serve clinicians as a guide for counseling.

摘要

炎症性肠病(IBD)的家族聚集现象已被证实数十年,这反映了共同的遗传和环境易感性。家族史阳性仍然是IBD发病最明显的风险因素,约8%-12%的IBD患者有家族史。克罗恩病比溃疡性结肠炎表现出更常见的家族模式。受累先证者的一级亲属患IBD的风险增加4至8倍。双胞胎以及父母双方均患有IBD的孩子患IBD的风险也显著更高;有描述称受影响家庭成员数量存在累积效应,受影响成员为三人或更多的家庭发病率最高。在此,我们综述了有关家族性IBD的现有证据,并简要讨论IBD在不同种族和民族中的差异,希望能提供有用的更新内容和实用指南,为临床医生提供咨询指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121b/5759609/116962b44f3b/AnnGastroenterol-31-14-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121b/5759609/116962b44f3b/AnnGastroenterol-31-14-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/121b/5759609/116962b44f3b/AnnGastroenterol-31-14-g003.jpg

相似文献

1
Familial and ethnic risk in inflammatory bowel disease.炎症性肠病中的家族和种族风险。
Ann Gastroenterol. 2018 Jan-Feb;31(1):14-23. doi: 10.20524/aog.2017.0208. Epub 2017 Oct 26.
2
Familial occurrence and inheritance studies in inflammatory bowel disease.炎症性肠病的家族发病情况及遗传研究。
Neth J Med. 1996 Feb;48(2):53-6. doi: 10.1016/0300-2977(95)00093-3.
3
Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis.溃疡性结肠炎患者炎症性肠病的家族聚集性。
Intest Res. 2017 Jul;15(3):388-394. doi: 10.5217/ir.2017.15.3.388. Epub 2017 Jun 12.
4
Familial risk of inflammatory bowel disease: a population-based cohort study 1977-2011.炎症性肠病的家族风险:一项基于人群的队列研究(1977 - 2011年)
Am J Gastroenterol. 2015 Apr;110(4):564-71. doi: 10.1038/ajg.2015.50. Epub 2015 Mar 24.
5
Familial occurrence of inflammatory bowel disease in Korea.韩国炎症性肠病的家族聚集性。
Inflamm Bowel Dis. 2006 Dec;12(12):1146-51. doi: 10.1097/01.mib.0000235094.01608.59.
6
Familial and sporadic inflammatory bowel disease: different entities?家族性和散发性炎症性肠病:不同的实体?
Inflamm Bowel Dis. 2000 Nov;6(4):314-20. doi: 10.1002/ibd.3780060409.
7
Investigation of inflammatory bowel disease risk factors in 4 families in central China.中国中部4个家庭炎症性肠病风险因素的调查
Exp Ther Med. 2018 Feb;15(2):1367-1375. doi: 10.3892/etm.2017.5582. Epub 2017 Nov 28.
8
Familial occurrence of inflammatory bowel disease in celiac disease.乳糜泻患者炎症性肠病的家族聚集性。
Inflamm Bowel Dis. 2003 Sep;9(5):321-3. doi: 10.1097/00054725-200309000-00006.
9
Influence of a Positive Family History on the Clinical Course of Inflammatory Bowel Disease.家族遗传史对炎症性肠病临床病程的影响。
J Crohns Colitis. 2016 Sep;10(9):1024-32. doi: 10.1093/ecco-jcc/jjw063. Epub 2016 Mar 1.
10
Familial aggregation of inflammatory bowel disease in India: prevalence, risks and impact on disease behavior.印度炎症性肠病的家族聚集性:患病率、风险及对疾病行为的影响。
Intest Res. 2019 Oct;17(4):486-495. doi: 10.5217/ir.2018.00174. Epub 2019 Aug 6.

引用本文的文献

1
Bidirectional Risk Association Between Hidradenitis Suppurativa and Inflammatory Bowel Disease.化脓性汗腺炎与炎症性肠病之间的双向风险关联
Acta Derm Venereol. 2025 Jul 3;105:adv43657. doi: 10.2340/actadv.v105.43657.
2
Gut virome: New key players in the pathogenesis of inflammatory bowel disease.肠道病毒组:炎症性肠病发病机制中的新关键因素。
World J Methodol. 2025 Jun 20;15(2):92592. doi: 10.5662/wjm.v15.i2.92592.
3
Inflammatory Bowel Disease in Children: Current Diagnosis and Treatment Strategies.儿童炎症性肠病:当前的诊断与治疗策略

本文引用的文献

1
Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis.溃疡性结肠炎患者炎症性肠病的家族聚集性。
Intest Res. 2017 Jul;15(3):388-394. doi: 10.5217/ir.2017.15.3.388. Epub 2017 Jun 12.
2
Ulcerative colitis.溃疡性结肠炎。
Lancet. 2017 Apr 29;389(10080):1756-1770. doi: 10.1016/S0140-6736(16)32126-2. Epub 2016 Dec 1.
3
Crohn's disease.克罗恩病。
Cureus. 2025 Feb 3;17(2):e78462. doi: 10.7759/cureus.78462. eCollection 2025 Feb.
4
Prevalence, Clinical Features, and Extraintestinal Manifestations in Patients with Familial Inflammatory Bowel Diseases.家族性炎症性肠病患者的患病率、临床特征及肠外表现
Dig Dis Sci. 2025 Apr;70(4):1467-1476. doi: 10.1007/s10620-025-08868-5. Epub 2025 Feb 13.
5
Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches.炎症性肠病治疗靶点的进展:新出现的目标与精准医学方法
Pharmaceuticals (Basel). 2025 Jan 10;18(1):78. doi: 10.3390/ph18010078.
6
[Update on the pathophysiology, prediction and prevention of inflammatory bowel diseases].[炎症性肠病的病理生理学、预测与预防的最新进展]
Inn Med (Heidelb). 2025 Feb;66(2):137-145. doi: 10.1007/s00108-024-01838-5. Epub 2025 Jan 20.
7
Exploring gut microbiota as a novel therapeutic target in Crohn's disease: Insights and emerging strategies.探索肠道微生物群作为克罗恩病的新型治疗靶点:见解与新兴策略。
World J Gastroenterol. 2025 Jan 14;31(2):100827. doi: 10.3748/wjg.v31.i2.100827.
8
Plasma protein-based and polygenic risk scores serve complementary roles in predicting inflammatory bowel disease.基于血浆蛋白和多基因风险评分在预测炎症性肠病中发挥着互补作用。
Pac Symp Biocomput. 2025;30:522-534. doi: 10.1142/9789819807024_0037.
9
Modulation of Orosomucoid-like Protein 3 Activity in the Management of Inflammatory Bowel Disease.类orosomucoid蛋白3活性调节在炎症性肠病治疗中的作用
J Biotechnol Biomed. 2024;7(4):433-444. doi: 10.26502/jbb.2642-91280167. Epub 2024 Oct 18.
10
Navigating Reproductive Care in Patients With Inflammatory Bowel Disease: A Comprehensive Review.导航炎症性肠病患者的生殖护理:全面综述。
J Crohns Colitis. 2024 Oct 30;18(Supplement_2):ii16-ii30. doi: 10.1093/ecco-jcc/jjae048.
Lancet. 2017 Apr 29;389(10080):1741-1755. doi: 10.1016/S0140-6736(16)31711-1. Epub 2016 Dec 1.
4
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease.了解和预防炎症性肠病的全球增长。
Gastroenterology. 2017 Feb;152(2):313-321.e2. doi: 10.1053/j.gastro.2016.10.020. Epub 2016 Oct 25.
5
Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and Differences.美国炎症性肠病中的种族和少数民族:疾病特征及差异的系统评价
Inflamm Bowel Dis. 2016 Aug;22(8):2023-40. doi: 10.1097/MIB.0000000000000835.
6
A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF.在阿什肯纳兹犹太人中占主导地位的CSF2RB移码突变增加了克罗恩病的风险,并通过粒细胞-巨噬细胞集落刺激因子降低单核细胞信号传导。
Gastroenterology. 2016 Oct;151(4):710-723.e2. doi: 10.1053/j.gastro.2016.06.045. Epub 2016 Jul 1.
7
Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities.炎症性肠病的临床前疾病与预防策略:观点、挑战与机遇
Gut. 2016 Jul;65(7):1061-9. doi: 10.1136/gutjnl-2016-311785. Epub 2016 May 3.
8
Influence of a Positive Family History on the Clinical Course of Inflammatory Bowel Disease.家族遗传史对炎症性肠病临床病程的影响。
J Crohns Colitis. 2016 Sep;10(9):1024-32. doi: 10.1093/ecco-jcc/jjw063. Epub 2016 Mar 1.
9
Perception of Reproductive Health in Women with Inflammatory Bowel Disease.炎症性肠病女性对生殖健康的认知
J Crohns Colitis. 2016 Aug;10(8):886-91. doi: 10.1093/ecco-jcc/jjw011. Epub 2016 Jan 18.
10
Hospital Admissions, Biological Therapy, and Surgery in Familial and Sporadic Cases of Inflammatory Bowel Disease: A Population-Based Cohort Study 1977-2011.1977 - 2011年炎症性肠病家族性和散发性病例的住院治疗、生物治疗及手术:一项基于人群的队列研究
Inflamm Bowel Dis. 2015 Dec;21(12):2825-32. doi: 10.1097/MIB.0000000000000545.